Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Neurol Sci. 2020 Nov 22;42(7):2911–2919. doi: 10.1007/s10072-020-04910-8

Fig. 2.

Fig. 2

Ex-4 treatment resulted in a hypoactive phenotype during probe testing. Control males ambulated more than Ex-4-treated males in the easy (a; t(10)=1.925, p=0.0831) and difficult (b; t(9)=2.079, p=0.0677) probes, although these did not reach the level of significance. Females administered Ex-4 moved significantly less than saline-treated females in both the easy (c; t(18)=4.292, p<0.001) and difficult (d; t(17)=4.878, p<0.001) probe trials. † p<0.1; *** p<0.001